Lipoprotein-associated phospholipase A2 (LpPLA2), cardiovascular events and mortality in patients with type 2 diabetes mellitus on hemodialysis

被引：0
|
作者：
Maerz, W. [1 ]
Genser, B. [1 ]
Benz, J. [2 ]
Drechlser, C. [3 ]
Krane, V. [3 ]
Grammer, T. B. [1 ]
Ritz, E. [4 ]
Scharnagl, H. [5 ]
Wanner, C. [3 ]
机构：
[1] Univ Heidelberg, Inst Publ Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany
[2] Synlab Ctr Lab Diagnost, Leinfelden Echterdingen, Germany
[3] Univ Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[4] Med Fac Heidelberg, Heidelberg, Germany
[5] Med Univ Graz, Dept Lab Med, Graz, Austria
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1077 / 1077
页数：1
相关论文
共 50 条
  • [1] Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on hemodialysis
    Winkler, K.
    Hoffmann, M. M.
    Krane, V.
    Drechsler, C.
    Wanner, C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 444 - 444
  • [2] Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
    Rolla, Roberta
    De Mauri, Andreana
    Valsesia, Ambra
    Vidali, Matteo
    Chiarinotti, Doriana
    Bellomo, Giorgio
    JOURNAL OF NEPHROLOGY, 2015, 28 (06) : 749 - 755
  • [3] Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
    Roberta Rolla
    Andreana De Mauri
    Ambra Valsesia
    Matteo Vidali
    Doriana Chiarinotti
    Giorgio Bellomo
    Journal of Nephrology, 2015, 28 : 749 - 755
  • [4] Lipoprotein-associated phospholipase A2 predicts cardiovascular events
    Persson, M
    Nilsson, JA
    Hedblad, B
    Nelson, JJ
    Berglund, G
    CIRCULATION, 2005, 112 (17) : U868 - U868
  • [5] Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients
    De Mauri, Andreana
    Vidali, Matteo
    Chiarinotti, Doriana
    Bellomo, Giorgio
    Rolla, Roberta
    JOURNAL OF NEPHROLOGY, 2019, 32 (02) : 283 - 288
  • [6] Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients
    Andreana De Mauri
    Matteo Vidali
    Doriana Chiarinotti
    Giorgio Bellomo
    Roberta Rolla
    Journal of Nephrology, 2019, 32 : 283 - 288
  • [7] Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis
    Winkler, Karl
    Hoffmann, Michael M.
    Krane, Vera
    Drechsler, Christiane
    Wanner, Christoph
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (07) : 693 - 701
  • [8] Race/Ethnic differences and coronary risk factor associations of lipoprotein-associated phospholipase A2 (LpPLA2) in an older asymptomatic cohort
    Fair, Joan M.
    Kiazand, Alexandre
    Mahbouba, Mohammed H.
    Norton, Linda C.
    Go, Alan S.
    Austin, Melissa A.
    Fortmann, Stephen P.
    Iribarren, Carlos
    CIRCULATION, 2006, 114 (18) : 869 - 869
  • [9] Lipoprotein-associated phospholipase A2, and subsequent cardiovascular events and mortality among patients with coronary heart disease
    Benderly, Michal
    Sapir, Batya
    Kalter-Leibovici, Ofra
    Zimlichman, Reuven
    BIOMARKERS, 2017, 22 (3-4) : 219 - 224
  • [10] Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus
    Fortunato, J.
    Blaha, V.
    Bis, J.
    St'asek, J.
    Andrys, C.
    Vojacek, J.
    Juraskova, B.
    Sobotka, L.
    Polansky, P.
    Brtko, M.
    JOURNAL OF DIABETES RESEARCH, 2014, 2014
12345